NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...
AiCuris Anti-infective Cures AG today announced the initiation of its Phase 1, first-in-human trial of AIC468, a novel antisense oligonucleotide. AIC468 is an antiviral agent which aims to treat BK ...
The breakthrough treatment uses cutting-edge DNA sequencing that may help millions of people ... A new therapeutic virus, RP1, has been created from the herpes simplex virus, which causes cold sores.